FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40206011000001100: Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2503371000001116 Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2503381000001119 Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) Is a Cenobamate 12.5mg tablets and Cenobamate 25mg tablets true Inferred relationship Existential restriction modifier
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) Is a Ontozry true Inferred relationship Existential restriction modifier
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) 28 tablet 1 x (14tabs+14tabs) Has AMP True Ontozry 12.5mg/25mg tablets treatment initiation pack (Angelini Pharma UK-I Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start